Have your own idea? Try our Stock Screener
Japanese (NIKKEI) Life Sciences Industry Analysis
UpdatedMay 29, 2026
DataAggregated Company Financials
Companies13
- 7D-3.4%
- 3M-23.3%
- 1Y-12.2%
- YTD-19.6%
Over the last 7 days, the Life Sciences industry has dropped 3.4%, driven by a pullback from Shin Nippon Biomedical Laboratories of 5.2%. The industry has fallen 12% in the last year. As for the next few years, earnings are expected to grow by 18% per annum.
Industry Valuation and Performance
Has the Japanese Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 29 May 2026 | JP¥116.8b | JP¥62.9b | JP¥618.3m | 25.9x | 188.9x | 1.9x |
| Sun, 26 Apr 2026 | JP¥140.0b | JP¥63.3b | -JP¥864,496,000.00 | 22x | -161.9x | 2.2x |
| Tue, 24 Mar 2026 | JP¥136.8b | JP¥63.3b | -JP¥865,584,000.00 | 21x | -158.1x | 2.2x |
| Thu, 19 Feb 2026 | JP¥159.8b | JP¥63.2b | -JP¥944,048,000.00 | 27.7x | -169.3x | 2.5x |
| Sat, 17 Jan 2026 | JP¥154.0b | JP¥66.9b | JP¥72.2m | 22.2x | 2133.5x | 2.3x |
| Mon, 15 Dec 2025 | JP¥156.1b | JP¥67.6b | JP¥684.4m | 17.8x | 228.1x | 2.3x |
| Wed, 12 Nov 2025 | JP¥136.1b | JP¥67.6b | JP¥897.4m | 15.7x | 151.6x | 2x |
| Fri, 10 Oct 2025 | JP¥144.5b | JP¥66.5b | JP¥1.5b | 16.5x | 99x | 2.2x |
| Sun, 07 Sep 2025 | JP¥148.3b | JP¥66.5b | JP¥1.5b | 16.7x | 101.6x | 2.2x |
| Tue, 05 Aug 2025 | JP¥140.5b | JP¥66.0b | JP¥1.1b | 16.4x | 124.5x | 2.1x |
| Thu, 03 Jul 2025 | JP¥139.0b | JP¥66.0b | JP¥1.1b | 16.4x | 123x | 2.1x |
| Sat, 31 May 2025 | JP¥139.6b | JP¥66.0b | JP¥1.1b | 17.7x | 123.2x | 2.1x |
| Mon, 28 Apr 2025 | JP¥135.7b | JP¥64.2b | JP¥1.5b | 14.5x | 88.3x | 2.1x |
| Wed, 26 Mar 2025 | JP¥160.3b | JP¥64.8b | JP¥927.4m | 15.4x | 172.9x | 2.5x |
| Fri, 21 Feb 2025 | JP¥165.1b | JP¥65.1b | JP¥1.1b | 15.6x | 148x | 2.5x |
| Sun, 19 Jan 2025 | JP¥159.0b | JP¥62.0b | JP¥440.7m | 17.5x | 360.9x | 2.6x |
| Tue, 17 Dec 2024 | JP¥161.0b | JP¥62.0b | JP¥440.7m | 16.8x | 365.2x | 2.6x |
| Thu, 14 Nov 2024 | JP¥157.9b | JP¥62.6b | JP¥1.3b | 20.7x | 118.8x | 2.5x |
| Sat, 12 Oct 2024 | JP¥149.4b | JP¥61.5b | JP¥1.8b | 17.5x | 81.2x | 2.4x |
| Mon, 09 Sep 2024 | JP¥156.3b | JP¥61.6b | JP¥2.1b | 18.6x | 75.6x | 2.5x |
| Wed, 07 Aug 2024 | JP¥136.7b | JP¥61.8b | JP¥3.2b | 20x | 42.2x | 2.2x |
| Fri, 05 Jul 2024 | JP¥167.5b | JP¥61.8b | JP¥3.2b | 26.1x | 51.8x | 2.7x |
| Sun, 02 Jun 2024 | JP¥161.5b | JP¥61.8b | JP¥3.3b | 25.1x | 49.3x | 2.6x |
| Tue, 30 Apr 2024 | JP¥180.4b | JP¥62.3b | JP¥3.3b | 14.1x | 54.8x | 2.9x |
| Thu, 28 Mar 2024 | JP¥234.1b | JP¥155.4b | JP¥8.6b | 14.2x | 27.2x | 1.5x |
| Sat, 24 Feb 2024 | JP¥231.3b | JP¥155.3b | JP¥8.7b | 14.7x | 26.6x | 1.5x |
| Mon, 22 Jan 2024 | JP¥224.2b | JP¥167.1b | JP¥8.5b | 15.2x | 26.4x | 1.3x |
| Wed, 20 Dec 2023 | JP¥224.9b | JP¥167.1b | JP¥8.5b | 14.9x | 26.5x | 1.3x |
| Fri, 17 Nov 2023 | JP¥231.6b | JP¥168.1b | JP¥9.1b | 14.7x | 25.4x | 1.4x |
| Sun, 15 Oct 2023 | JP¥232.4b | JP¥179.3b | JP¥12.8b | 14.6x | 18.2x | 1.3x |
| Tue, 12 Sep 2023 | JP¥261.6b | JP¥179.3b | JP¥12.8b | 16.1x | 20.5x | 1.5x |
| Thu, 10 Aug 2023 | JP¥276.7b | JP¥179.9b | JP¥13.8b | 17.8x | 20x | 1.5x |
| Sat, 08 Jul 2023 | JP¥280.9b | JP¥178.5b | JP¥16.2b | 17.1x | 17.3x | 1.6x |
| Mon, 05 Jun 2023 | JP¥290.0b | JP¥178.3b | JP¥16.2b | 17x | 17.9x | 1.6x |
Price to Earnings Ratio
17.9x
Current Industry PE
- Investors are optimistic on the Japanese Life Sciences industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 189x which is higher than its 3-year average PE of 171x.
- The 3-year average PS ratio of 2.1x is higher than the industry's current PS ratio of 1.9x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have declined 66% per year over the last three years,
- Revenues have also declined 29% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | 1.50% | |
| Healthcare | -1.22% | |
| Life Sciences | -3.36% | |
| Clinical Research and Equipment | -3.36% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4241 atect | JP¥699.00 | 5.9% +JP¥172.4m | 80.2% | PE21.9x | |
| 130A Veritas In Silico | JP¥416.00 | 4.3% +JP¥110.3m | -39.5% | PS29.6x | |
| 7079 WDB coco | JP¥2.58k | 0.7% +JP¥45.7m | -11.6% | PE9.1x |